Dr Florence Gschwend is co-founder and CEO of Chrysalix Technologies, an Imperial College spin-out company commercialising the BioFlex process, a circular bio-economy technology. A chemist by training, she co-founded Chrysalix after completing her PhD in Chemical Engineering. The BioFlex process enables the use of unwanted waste wood for the production of renewable chemicals, material and fuels. Dr Gschwend has won several awards in relation to it and was named by Forbes 30under30 as one of Europe’s most promising game changers under 30 in Science and Healthcare.
